MolnupiravirInfluenza Antiviral (Systemic Antiviral) Indication: Indicated for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness. Dosage & Administration: The recommended dose is 800 mg (four 200 mg capsules) taken orally every 12 hours […]